News

Despite of comparatively small term of state program action, the import substitution of medications is taken place in market of Kazakhstan; thereby is reformed the sector and increased the level of home-produced medicines that is supported population by effective, safe, qualitative and affordable price.

LLP “VIVA PHARM” is actively supported the policy of import substitution and extended the range of generic medicines that are being produced. We are informing about termination of registration of medicine named “Captopril H VIVA PHARM”; that was came instead of imported medicine named “CAPOZIDE”. It is combined medication, which had proved hypotensive and diuretic action. For medicine-generic which “Captopril H VIVA PHARM” is, the ideal is its bioequivalence with original, i.e the identity according to basic pharmacokinetic parameters. Thank to correctly matched formulation, optimal technology and quality of production processes was achieved the positive result of researches on bioequivalence.